The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Fierce BioTech

DECEMBER 23, 2024

First-in-Human, Drug-Drug Interaction, Food Effect, Bioequivalence, etc.), and often require consistent batches of drug product be administered to groups of research participants within a short timeframe, early phase studies present unique challenges for drug developers not typically experienced in later stages of development.

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Development 52

Conversations in Drug Development Trends

AUGUST 10, 2023

We Have an Opportunity to Improve from Past Experiences The history of clinical research is full of shortcomings, including the unethical treatment of research participants and the exclusion of members of racial and ethnic minority groups and the LGBTQIA+ community.

Science 98

Science Clinical Trials Trials Clinical Research 98

Fierce BioTech

MARCH 12, 2024

For biopharma and biotech companies, FSP partnerships have emerged as a pivotal strategy for accessing the complementary expertise and resource flexibility they need to meet their timelines, and innovative providers are implementing new, globalized FSP strategies to keep their clients ahead of the curve.

Clinical Research 52

Clinical Research Drug Development Trials Research 52

Alta Sciences

JULY 22, 2024

Insights in FIH studies provide valuable information on potential dosing, efficacy, and safety, and serve as a good guide for the regulatory requirements needed throughout clinical development. jpg Tags Clinical Trials Weight 1

Trials 52

Trials Clinical Trials Clinical Development Clinical Research 52

Conversations in Drug Development Trends

JUNE 13, 2024

At Worldwide, Matt Cooper and Jim Eamma , our Executive Directors, Therapeutic Strategy Leads in Oncology, shed light on the intricacies of modern oncology trials in their recent webinar, “ Navigating the Landscape of Complex & Adaptive Oncology Trials.”

Trials 52

Trials Clinical Trials Drug Development Clinical Development 52

Conversations in Drug Development Trends

FEBRUARY 26, 2024

However, incorporating the patient experience into your design is one of the best ways to ensure your drug development program is a commercial success. In our recent Xtalks webinar, “ See How It’s Done: Case Studies on Patient Experience Design ,” our Therapeutic Strategy Lead, Rare Disease, Juliane K.

Clinical Trials 59

Clinical Trials Trials Disease Clinical Research 59

Conversations in Drug Development Trends

FEBRUARY 22, 2023

Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!

Disease 52

Disease Clinical Trials Trials Treatment 52

PPD

OCTOBER 16, 2023

This enables deeper and more meaningful real-world insights on clinical study data. Tokenization can accelerate innovation in clinical trials and drug development. Once in the data lake, tokenized data can be linked using a special linking software based on the data usage agreements to create longitudinal patient data.

Clinical Trials 98

Clinical Trials Trials Research Therapies 98

Conversations in Drug Development Trends

JUNE 21, 2024

The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. Check out this webinar on navigating the landscape of oncology clinical trials.

Clinical Trials 64

Clinical Trials Clinical Research Therapies Immune Response 64

Alta Sciences

JULY 18, 2023

Top Nonclinical Scientific Resources The Altascientist Issue 32: A Changing Paradigm for Non-rodent Species in Nonclinical Safety Studies Though historically used predominantly in dermal and wound healing research, an increasing body of evidence supports the use of miniature swine as a viable non-rodent option for your nonclinical safety studies.

Science 40

Science Clinical Trials FDA Trials 40

Agency IQ

OCTOBER 27, 2023

Start Date End Date Event Event Type Center 10/30/2023 10/30/2023 Defining ‘Candy-Like’ Nonprescription Drug Products Workshop CDER 10/31/2023 10/31/2023 Cellular, Tissue, and Gene Therapies Advisory Committee Advisory Committee Meeting CBER 10/31/2023 10/31/2023 Webinar – Proposed Rule: Medical Devices; Laboratory Developed Tests (..)

FDA 40

FDA Science Regulations Production 40

Agency IQ

MARCH 1, 2024

Start Date End Date Event Event Type Center 02/26/2024 02/26/2024 FDA/CDER and American Association of Pharmaceutical Scientists (AAPS) Hybrid Public Workshop Public CDER 02/27/2024 02/27/2024 FDA Oncology Center of Excellence Presents: Conversations on Cancer, Black History Month Program: “Real Talk: Our Stories as Black Oncologists at the FDA” Webcast (..)

FDA 40

FDA Science Clinical Trials Regulations 40

Agency IQ

FEBRUARY 2, 2024

Start Date End Date Event Event Type Center 01/10/2024 01/10/2024 FDA Oncology Center of Excellence Presents: Conversations on Cancer: “Bringing Innovation to People Facing Cancer” Webcast Office of the Commissioner 01/26/2024 01/26/2024 Medical Device Sterilization Town Hall: FDA Activities and Challenges in Reducing Reliance on Ethylene Oxide (EtO) (..)

FDA 40

FDA Science Clinical Trials Regulations 40

BioPharma Drive: Drug Pricing

JUNE 9, 2025

However, with this kind of promise comes more scientific, ethical and financial questions that healthcare providers and drug development professionals must seriously consider. He is certified in Internal Medicine and Gastroenterology and is also a Fellow of the American College of Gastroenterology.

Clinical Trials 141

Clinical Trials Drugs Therapies Clinical Supply 141

Conversations in Drug Development Trends

MARCH 11, 2025

To address these concerns in CAR T therapy trials , Worldwides Dr. Simran Padam, Dr. Amy Raymond, and Nathan Chadwick discussed with Dr. Chris Jenkins of Sabai Global and Dr. Tahseen Mozaffar of UC Irvine in an on-demand webinar, Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations.

Clinical Trials 40

Clinical Trials Trials Therapies Treatment 40